News

A Novel AI – Derived Metric Identifies Favorable Candidates of Focal Therapy of Prostate Cancer and Accurately Predicts Treatment Margin Efficacy

Automatic Ablation Site Selection for Focal Therapy

Defining Prostate Cancer Focal Therapy Treatment Margins with a Machine Learning Model: Improvement Upon Hemi-Gland Ablation

iQuest Clinical Validation Efforts

First AI-Powered Precision Oncology Platform for Prostate Cancer Care, iQuestTM, Receives FDA Clearance

December 13, 2022

Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance

December 11, 2022

Could an Emerging AI Platform Supplant Traditional MRI for Assessing Prostate Cancer?

December 7, 2022

News, Recognition

Avenda Health Adds Tech Luminary to Board of Directors and Expands Leadership Team

August 26, 2022